Enliven Therapeutics
ELVN
#5628
Rank
HK$7.09 B
Marketcap
HK$144.64
Share price
-1.37%
Change (1 day)
3.89%
Change (1 year)

EPS for Enliven Therapeutics (ELVN)

EPS in 2023 (TTM): -HK$12.04

According to Enliven Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$11.90. In 2021 the company made an earnings per share (EPS) of -HK$4.67 a decrease over its 2020 EPS that were of -HK$3.58.

EPS history for Enliven Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$12.04
2021-HK$4.6730.44%
2020-HK$3.58